HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased risk of adverse pregnancy outcomes among women affected by herpangina.

AbstractOBJECTIVE:
This population-based study aimed to assess the relation between herpangina and adverse pregnancy outcomes: low birthweight (LBW), small for gestational age (SGA), and preterm delivery.
STUDY DESIGN:
A total of 242 pregnant women who had singleton births and who visited ambulatory care centers for the treatment of herpangina were assessed, together with 1936 matched women as a comparison group. Conditional logistic regression analyses were performed to examine the risk of LBW, preterm birth, and SGA for mothers with herpangina and unaffected mothers.
RESULTS:
Compared with pregnant women without herpangina, herpangina was associated with a 2.29- (95% confidence interval [CI], 1.42-3.69), 1.67- (95% CI, 1.04-2.68), and 1.63-fold (95% CI, 1.14-2.33) increased risk of having LBW, preterm, and SGA infants, respectively, after adjusting for family income and maternal and infant characteristics.
CONCLUSION:
Our findings highlight a significant potential risk posed by herpangina, a usually mild disease, among pregnant women.
AuthorsYi-Hua Chen, Hsiu-Chen Lin, Herng-Ching Lin
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 203 Issue 1 Pg. 49.e1-7 (Jul 2010) ISSN: 1097-6868 [Electronic] United States
PMID20417474 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2010 Mosby, Inc. All rights reserved.
Topics
  • Adult
  • Chi-Square Distribution
  • Cohort Studies
  • Enterovirus (isolation & purification)
  • Female
  • Herpangina (epidemiology, virology)
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infant, Small for Gestational Age
  • Male
  • Pregnancy
  • Pregnancy Complications, Infectious (epidemiology, virology)
  • Premature Birth
  • Taiwan (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: